{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:05:56Z","timestamp":1784693156710,"version":"3.55.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ft\u0131rma Kurumu","doi-asserted-by":"publisher","award":["117S065"],"award-info":[{"award-number":["117S065"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["DARU J Pharm Sci"],"DOI":"10.1007\/s40199-026-00625-x","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T03:52:16Z","timestamp":1784692336000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Novel 3,3\u2032-diindolylmethane derivatives as multi-pathway modulators: targeting estrogen-dependent and independent breast cancer carcinogenesis"],"prefix":"10.1007","volume":"34","author":[{"given":"Elif","family":"Ince-Erguc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bita","family":"Entezari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanif","family":"Sirinzade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibel","family":"Suzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atilla","family":"Akdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oguz","family":"Erdogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4890-299X","authenticated-orcid":false,"given":"Hande","family":"Gurer-Orhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"625_CR1","doi-asserted-by":"publisher","first-page":"e20224","DOI":"10.1016\/j.heliyon.2023.e20224","volume":"9","author":"K Al-Shami","year":"2023","unstructured":"Al-Shami K, Awadi S, Khamees A, Alsheikh AM, Al-Sharif S, Ala\u2019 Bereshy R, Al-Eitan SF, Banikhaled SH, Al-Qudimat AR, Al-Zoubi RM. Al Zoubi, Estrogens and the risk of breast cancer: A narrative review of literature. Heliyon. 2023;9:e20224. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e20224.","journal-title":"Heliyon"},{"key":"625_CR2","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1158\/1055-9965.EPI-14-0884","volume":"24","author":"J Lecarpentier","year":"2015","unstructured":"Lecarpentier J, Nogu\u00e8s C, Mouret-Fourme E, Buecher B, Gauthier-Villars M, Stoppa-Lyonnet D, Bonadona V, Fricker JP, Berthet P, Caron O, Coupier I, Pujol P, Faivre L, Gesta P, Eisinger F, Mari V, Gladieff L, Lortholary A, Luporsi E, Leroux D, Venat-Bouvet L, Maugard CM, Colas C, Tinat J, Lasset C, Andrieu N. Breast cancer risk associated with estrogen exposure and truncating mutation location in BRCA1\/2 carriers, Cancer Epidemiol. Biomarkers Prev. 2015;24:698\u2013707. https:\/\/doi.org\/10.1158\/1055-9965.EPI-14-0884.","journal-title":"Biomarkers Prev"},{"key":"625_CR3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.steroids.2014.08.006","volume":"99","author":"JD Yager","year":"2015","unstructured":"Yager JD. Mechanisms of estrogen carcinogenesis: The role of E2\/E1\u2013quinone metabolites suggests new approaches to preventive intervention \u2013 A review. Steroids. 2015;99:56\u201360. https:\/\/doi.org\/10.1016\/j.steroids.2014.08.006.","journal-title":"Steroids"},{"key":"625_CR4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.steroids.2012.11.001","volume":"78","author":"W Yue","year":"2013","unstructured":"Yue W, Yager JD, Wang JP, Jupe ER, Santen RJ. Estrogen receptor-dependent and independent mechanisms of breast cancer carcinogenesis. Steroids. 2013;78:161\u201370. https:\/\/doi.org\/10.1016\/j.steroids.2012.11.001.","journal-title":"Steroids"},{"key":"625_CR5","doi-asserted-by":"publisher","unstructured":"Schuster EF, Lopez-Knowles E, Alataki A, Zabaglo L, Folkerd E, Evans D, Sidhu K, Cheang MCU, Tovey H, Salto-Tellez M, Maxwell P, Robertson J, Smith I, Bliss JM, Dowsett M. Molecular profiling of aromatase inhibitor sensitive and resistant ER+HER2- postmenopausal breast cancers. Nat Commun. 2023;14. https:\/\/doi.org\/10.1038\/s41467-023-39613-z.","DOI":"10.1038\/s41467-023-39613-z"},{"key":"625_CR6","doi-asserted-by":"publisher","unstructured":"Rani S, Raheja K, Luxami V, Paul K. A review on diverse heterocyclic compounds as the privileged scaffolds in non-steroidal aromatase inhibitors. Bioorg Chem. 2021;113. https:\/\/doi.org\/10.1016\/j.bioorg.2021.105017.","DOI":"10.1016\/j.bioorg.2021.105017"},{"key":"625_CR7","doi-asserted-by":"publisher","unstructured":"Williams DE. Indoles derived from glucobrassicin: Cancer chemoprevention by indole-3-carbinol and 3,3\u2032-diindolylmethane. Front Nutr. 2021;8. https:\/\/doi.org\/10.3389\/fnut.2021.734334.","DOI":"10.3389\/fnut.2021.734334"},{"key":"625_CR8","doi-asserted-by":"publisher","unstructured":"Kaiser AE, Baniasadi M, Giansiracusa D, Giansiracusa M, Garcia M, Fryda Z, Wong TL, Bishayee A. Sulforaphane: A broccoli bioactive phytocompound with cancer preventive potential. Cancers (Basel). 2021;13. https:\/\/doi.org\/10.3390\/cancers13194796.","DOI":"10.3390\/cancers13194796"},{"key":"625_CR9","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1080\/01635580701458186","volume":"59","author":"RD Verschoyle","year":"2007","unstructured":"Verschoyle RD, Steward WP, Gescher AJ. Putative cancer chemopreventive agents of dietary origin - How safe are they? Nutr Cancer. 2007;59:152\u201362. https:\/\/doi.org\/10.1080\/01635580701458186.","journal-title":"Nutr Cancer"},{"key":"625_CR10","doi-asserted-by":"publisher","first-page":"795980","DOI":"10.3389\/fphys.2022.795980","volume":"13","author":"Q Zhou","year":"2022","unstructured":"Zhou Q, Wang Y, Han X, Fu S, Zhu C, Chen Q. Efficacy of resveratrol supplementation on glucose and lipid metabolism: A meta-analysis and systematic review. Front Physiol. 2022;13:795980. https:\/\/doi.org\/10.3389\/fphys.2022.795980.","journal-title":"Front Physiol"},{"key":"625_CR11","doi-asserted-by":"publisher","first-page":"173803","DOI":"10.1016\/j.ejphar.2020.173803","volume":"893","author":"H He","year":"2021","unstructured":"He H, Ma Y, Huang H, Huang C, Chen Z, Chen D, Gu Y, Wang X, Chen J. A comprehensive understanding about the pharmacological effect of diallyl disulfide other than its anti-carcinogenic activities. Eur J Pharmacol. 2021;893:173803. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173803.","journal-title":"Eur J Pharmacol"},{"key":"625_CR12","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1021\/acs.jnatprod.1c00618","volume":"84","author":"J Qian","year":"2021","unstructured":"Qian J, Xu Z, Zhu P, Meng C, Liu Y, Shan W, He A, Gu Y, Ran F, Zhang Y, Ling Y. A derivative of piperlongumine and ligustrazine as a potential thioredoxin reductase inhibitor in drug-resistant hepatocellular carcinoma. J Nat Prod. 2021;84:3161\u20138. https:\/\/doi.org\/10.1021\/acs.jnatprod.1c00618.","journal-title":"J Nat Prod"},{"key":"625_CR13","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1080\/10717544.2022.2056662","volume":"29","author":"P Ji","year":"2022","unstructured":"Ji P, Wang X, Yin J, Mou Y, Huang H, Ren Z. Selective delivery of curcumin to breast cancer cells by self-targeting apoferritin nanocages with pH-responsive and low toxicity. Drug Deliv. 2022;29:986\u201396. https:\/\/doi.org\/10.1080\/10717544.2022.2056662.","journal-title":"Drug Deliv"},{"key":"625_CR14","doi-asserted-by":"publisher","first-page":"073","DOI":"10.7324\/JAPS.2015.501112","volume":"5","author":"R Dash","year":"2015","unstructured":"Dash R, Hosen SMZ, Karim MR, Kabir MSH, Hossain MM, Junaid M, Islam A, Paul A, Khan MA. In silico analysis of indole-3-carbinol and its metabolite DIM as EGFR tyrosine kinase inhibitors in platinum resistant ovarian cancer vis a vis ADME\/T property analysis. J Appl Pharm Sci. 2015;5:073\u20138. https:\/\/doi.org\/10.7324\/JAPS.2015.501112.","journal-title":"J Appl Pharm Sci"},{"key":"625_CR15","doi-asserted-by":"publisher","unstructured":"Mitra S, Dash R. Natural products for the management and prevention of breast cancer, Evid.-Based Complement. Altern. Med. 2018 (2018). https:\/\/doi.org\/10.1155\/2018\/8324696","DOI":"10.1155\/2018\/8324696"},{"key":"625_CR16","doi-asserted-by":"publisher","first-page":"43147","DOI":"10.1021\/acsomega.2c05832","volume":"7","author":"D Penta","year":"2022","unstructured":"Penta D, Tripathi P, Rajarajan D, Natesh J, Mondal P, Meeran SM. Diindolylmethane promotes metabolic crisis and enhances the efficacy of centchroman in breast cancer: A 1H NMR-based approach. ACS Omega. 2022;7:43147\u201360. https:\/\/doi.org\/10.1021\/acsomega.2c05832.","journal-title":"ACS Omega"},{"key":"625_CR17","doi-asserted-by":"publisher","first-page":"118421","DOI":"10.1016\/j.bmc.2025.118421","volume":"132","author":"S Singh","year":"2026","unstructured":"Singh S, Gupta N, Mishra DP, Verma S. Diindolylmethane-containing peptides inhibit invasion and epithelial-mesenchymal transition-associated gene expression in hormone-dependent breast cancer. Bioorg Med Chem. 2026;132:118421. https:\/\/doi.org\/10.1016\/j.bmc.2025.118421.","journal-title":"Bioorg Med Chem"},{"key":"625_CR18","doi-asserted-by":"publisher","first-page":"6083","DOI":"10.1158\/0008-5472.CAN-08-3309","volume":"69","author":"S Fan","year":"2009","unstructured":"Fan S, Meng Q, Saha T, Sarkar FH, Rosen EM. Low concentrations of diindolylmethane, a metabolite of indole-3-carbinol, protect against oxidative stress in a BRCA1-dependent manner. Cancer Res. 2009;69:6083\u201391. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-3309.","journal-title":"Cancer Res"},{"key":"625_CR19","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1080\/13880209.2016.1192198","volume":"54","author":"W Wang","year":"2016","unstructured":"Wang W, Lv M, Wang Y, Zhang J. Development of novel application of 3,3\u2032-diindolylmethane: sensitizing multidrug resistance human breast cancer cells to \u03b3-irradiation. Pharm Biol. 2016;54:3164\u20138. https:\/\/doi.org\/10.1080\/13880209.2016.1192198.","journal-title":"Pharm Biol"},{"key":"625_CR20","doi-asserted-by":"publisher","unstructured":"Reyes-Hern\u00e1ndez OD, Figueroa-Gonz\u00e1lez G, Quintas-Granados LI, Guti\u00e9rrez-Ru\u00edz SC, Hern\u00e1ndez-Parra H, Romero-Montero A, Del Prado-Audelo ML, Bernal-Chavez SA, Cort\u00e9s H, Pe\u00f1a-Corona SI, Kiyekbayeva L, Ate\u015f\u015fahin DA, Goloshvili T, Leyva-G\u00f3mez G, Sharifi-Rad J. 3,3\u2032-diindolylmethane and indole-3-carbinol: Potential therapeutic molecules for cancer chemoprevention and treatment via regulating cellular signaling pathways. Cancer Cell Int. 2023;23. https:\/\/doi.org\/10.1186\/s12935-023-03031-4.","DOI":"10.1186\/s12935-023-03031-4"},{"key":"625_CR21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10549-017-4292-7","volume":"165","author":"CA Thomson","year":"2017","unstructured":"Thomson CA, Chow HHS, Wertheim BC, Roe DJ, Stopeck A, Maskarinec G, Altbach M, Chalasani P, Huang C, Strom MB, Galons JP, Thompson PA. A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen. Breast Cancer Res Treat. 2017;165:97\u2013107. https:\/\/doi.org\/10.1007\/s10549-017-4292-7.","journal-title":"Breast Cancer Res Treat"},{"key":"625_CR22","doi-asserted-by":"publisher","first-page":"5233","DOI":"10.1158\/1078-0432.CCR-04-0163","volume":"10","author":"MJ Anderton","year":"2004","unstructured":"Anderton MJ, Manson MM, Verschoyle RD, Gescher A, Lamb JH, Farmer PB, Steward WP, Williams ML. Pharmacokinetics and tissue disposition of indole-3-carbinol and its acid condensation products after oral administration to mice. Clin Cancer Res. 2004;10:5233\u201341. https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-0163.","journal-title":"Clin Cancer Res"},{"key":"625_CR23","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.foodchem.2013.01.113","volume":"139","author":"Y Luo","year":"2013","unstructured":"Luo Y, Wang TTY, Teng Z, Chen P, Sun J, Wang Q. Encapsulation of indole-3-carbinol and 3,3\u2032-diindolylmethane in zein\/carboxymethyl chitosan nanoparticles with controlled release property and improved stability. Food Chem. 2013;139:224\u201330. https:\/\/doi.org\/10.1016\/j.foodchem.2013.01.113.","journal-title":"Food Chem"},{"key":"625_CR24","doi-asserted-by":"publisher","first-page":"4136","DOI":"10.1016\/j.ejmech.2009.05.011","volume":"44","author":"D Maciejewska","year":"2009","unstructured":"Maciejewska D, Rasztawicka M, Wolska I, Anuszewska E, Gruber B. Novel 3,3\u2032-diindolylmethane derivatives: Synthesis and cytotoxicity, structural characterization in solid state. Eur J Med Chem. 2009;44:4136\u201347. https:\/\/doi.org\/10.1016\/j.ejmech.2009.05.011.","journal-title":"Eur J Med Chem"},{"key":"625_CR25","doi-asserted-by":"publisher","unstructured":"Ozcan-Sezer S, Ince E, Akdemir A, Ceylan \u00d6\u00d6, Suzen S, Gurer-Orhan H. Aromatase inhibition by 2-methyl indole hydrazone derivatives evaluated via molecular docking and in vitro activity studies. Xenobiotica. 2019;49. https:\/\/doi.org\/10.1080\/00498254.2018.1482029.","DOI":"10.1080\/00498254.2018.1482029"},{"key":"625_CR26","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0090-9556(25)05659-4","volume":"2","author":"MD Burke","year":"1974","unstructured":"Burke MD, Mayer RT. Ethoxyresorufin: direct fluorimetric assay of a microsomal O-dealkylation which is preferentially inducible by 3-methylcholanthrene. Drug Metab Dispos. 1974;2:583\u20138.","journal-title":"Drug Metab Dispos"},{"key":"625_CR27","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1289\/ehp.95103s7113","volume":"103","author":"AM Soto","year":"1995","unstructured":"Soto AM, Sonnenschein C, Chung KL, Fernandez MF, Olea N, Serrano FO. The E-SCREEN assay as a tool to identify estrogens: An update on estrogenic environmental pollutants. Environ Health Perspect. 1995;103:113\u201322. https:\/\/doi.org\/10.1289\/ehp.95103s7113.","journal-title":"Environ Health Perspect"},{"key":"625_CR28","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.2174\/1871530323666230224145624","volume":"23","author":"B Entezari","year":"2023","unstructured":"Entezari B, Bozdag D, Gurer-Orhan H. Evaluation of endocrine related adverse effects of non-endocrine targeted pharmaceuticals in cellular systems. Endocr Metab Immune Disord Drug Targets. 2023;23:1740\u20139. https:\/\/doi.org\/10.2174\/1871530323666230224145624.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"625_CR29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55\u201363. https:\/\/doi.org\/10.1016\/0022-1759(83)90303-4.","journal-title":"J Immunol Methods"},{"key":"625_CR30","doi-asserted-by":"publisher","unstructured":"Masetti M, Falchi F, Gioia D, Recanatini M, Ciurli S, Musiani F. Targeting the protein tunnels of the urease accessory complex: A theoretical investigation. Molecules. 2020;25. https:\/\/doi.org\/10.3390\/molecules25122911.","DOI":"10.3390\/molecules25122911"},{"key":"625_CR31","doi-asserted-by":"publisher","unstructured":"Mahmod AI, Haif SK, Kamal A, Al-ataby IA, Talib WH. Chemoprevention effect of the Mediterranean diet on colorectal cancer: Current studies and future prospects. Front Nutr. 2022;9. https:\/\/doi.org\/10.3389\/fnut.2022.924192.","DOI":"10.3389\/fnut.2022.924192"},{"key":"625_CR32","doi-asserted-by":"publisher","first-page":"4247","DOI":"10.21873\/anticanres.15924","volume":"42","author":"M Sukprasansap","year":"2022","unstructured":"Sukprasansap M, Chanvorachote P. Evidence of potential plant-derived compounds with anticancer effects on lung cancer: Clinical and molecular pharmacology approaches. Anticancer Res. 2022;42:4247\u201358. https:\/\/doi.org\/10.21873\/anticanres.15924.","journal-title":"Anticancer Res"},{"key":"625_CR33","doi-asserted-by":"publisher","unstructured":"Alharbi KS, Almalki WH, Makeen HA, Albratty M, Meraya AM, Nagraik R, Sharma A, Kumar D, Chellappan DK, Singh SK, Dua K, Gupta G. Role of medicinal plant-derived nutraceuticals as a potential target for the treatment of breast cancer. J Food Biochem. 2022;46. https:\/\/doi.org\/10.1111\/jfbc.14387.","DOI":"10.1111\/jfbc.14387"},{"key":"625_CR34","doi-asserted-by":"publisher","unstructured":"Kulkarni M, Hussain MA, Valdar RS, Hebbar S, Laha S. Exploring the cancer therapeutic potential of traditional medicinal plants by modulating the apoptotic pathway, Biomed. Res. Int. 2026 (2026). https:\/\/doi.org\/10.1155\/BMRI\/2086738","DOI":"10.1155\/BMRI\/2086738"},{"key":"625_CR35","doi-asserted-by":"publisher","unstructured":"Meer N, Elamin A, Mohammed F, Bashir F, Tayyem R. Dietary polyphenols as anticancer agents: A review of recent advances and mechanisms. Nutr Health. 2026;32. https:\/\/doi.org\/10.1177\/02601060251411197.","DOI":"10.1177\/02601060251411197"},{"key":"625_CR36","doi-asserted-by":"publisher","first-page":"868","DOI":"10.3390\/nu12030868","volume":"12","author":"L Mandrich","year":"2020","unstructured":"Mandrich L, Caputo E. Brassicaceae-derived anticancer agents: Towards a green approach to beat cancer. Nutrients. 2020;12:868. https:\/\/doi.org\/10.3390\/nu12030868.","journal-title":"Nutrients"},{"key":"625_CR37","doi-asserted-by":"publisher","first-page":"8054","DOI":"10.1080\/10408398.2023.2195493","volume":"64","author":"A Gasmi","year":"2024","unstructured":"Gasmi A, Gasmi Benahmed A, Shanaida M, Chirumbolo S, Menzel A, Anzar W, Arshad M, Cruz-Martins N, Lysiuk R, Beley N, Oliinyk P, Shanaida V, Denys A, Peana M, Bj\u00f8rklund G. Anticancer activity of broccoli, its organosulfur and polyphenolic compounds. Crit Rev Food Sci Nutr. 2024;64:8054\u201372. https:\/\/doi.org\/10.1080\/10408398.2023.2195493.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"625_CR38","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1007\/s00394-012-0455-9","volume":"52","author":"BE Licznerska","year":"2013","unstructured":"Licznerska BE, Szaefer H, Murias M, Bartoszek A, Baer-Dubowska W. Modulation of CYP19 expression by cabbage juices and their active components: Indole-3-carbinol and 3,3\u2032-diindolylmethene in human breast epithelial cell lines. Eur J Nutr. 2013;52:1483\u201392. https:\/\/doi.org\/10.1007\/s00394-012-0455-9.","journal-title":"Eur J Nutr"},{"key":"625_CR39","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/0022-4731(88)90128-8","volume":"30","author":"W Wouters","year":"1988","unstructured":"Wouters W, De Coster R, Goeminne N, Beerens D, van Dun J. Aromatase inhibition by the antifungal ketoconazole. J Steroid Biochem. 1988;30:387\u20139.","journal-title":"J Steroid Biochem"},{"key":"625_CR40","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1016\/j.bmcl.2016.04.078","volume":"26","author":"M Di Matteo","year":"2016","unstructured":"Di Matteo M, Ammazzalorso A, Andreoli F, Caffa I, De Filippis B, Fantacuzzi M, Giampietro L, Maccallini C, Nencioni A, Parenti MD, Soncini D, Del Rio A, Amoroso R. Synthesis and biological characterization of 3-(imidazol-1-ylmethyl) piperidine sulfonamides as aromatase inhibitors. Bioorg Med Chem Lett. 2016;26:3192\u20134. https:\/\/doi.org\/10.1016\/j.bmcl.2016.04.078.","journal-title":"Bioorg Med Chem Lett"},{"key":"625_CR41","doi-asserted-by":"publisher","unstructured":"Zhao M, Ma J, Li M, Zhang Y, Jiang B, Zhao X, Huai C, Shen L, Zhang N, He L, Qin S. Cytochrome P450 enzymes and drug metabolism in humans. Int J Mol Sci. 2021;22. https:\/\/doi.org\/10.3390\/ijms222312808.","DOI":"10.3390\/ijms222312808"},{"key":"625_CR42","doi-asserted-by":"publisher","first-page":"5793","DOI":"10.1158\/1078-0432.CCR-04-2545","volume":"11","author":"T Tokizane","year":"2005","unstructured":"Tokizane T, Shiina H, Igawa M, Enokida H, Urakami S, Kawakami T, Ogishima T, Okino ST, Li LC, Tanaka Y, Nonomura N, Okuyama A, Dahiya R. Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer, Clin. Cancer Res. 2005;11:5793\u2013801. https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-2545.","journal-title":"Cancer Res"},{"key":"625_CR43","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/0014-5793(95)01126-Y","volume":"374","author":"JA McKay","year":"1995","unstructured":"McKay JA, Melvin WT, Ah-See AK, Ewen SWB, Greenlee WF, Marcus CB, Burke MD, Murray GI. Expression of cytochrome P450 CYP1B1 in breast cancer. FEBS Lett. 1995;374:270\u20132. https:\/\/doi.org\/10.1016\/0014-5793(95)01126-Y.","journal-title":"FEBS Lett"},{"key":"625_CR44","doi-asserted-by":"publisher","unstructured":"Kwon YJ, Baek HS, Ye DJ, Shin S, Kim D, Chun YJ. CYP1B1 enhances cell proliferation and metastasis through induction of EMT and activation of Wnt\/\u03b2-catenin signaling via Sp1 upregulation. PLoS One. 2016;11. https:\/\/doi.org\/10.1371\/journal.pone.0151598.","DOI":"10.1371\/journal.pone.0151598"},{"key":"625_CR45","doi-asserted-by":"publisher","first-page":"4937","DOI":"10.2147\/OTT.S183192","volume":"12","author":"A Giudice","year":"2019","unstructured":"Giudice A, Barbieri A, Bimonte S, Cascella M, Cuomo A, Crispo A, D\u2019arena G, Galdiero M, Della Pepa ME, Botti G, Caraglia M, Capunzo M, Arra C, Montella M. Dissecting the prevention of estrogen-dependent breast carcinogenesis through Nrf2-dependent and independent mechanisms, Onco. Targets Ther. 2019;12:4937\u201353. https:\/\/doi.org\/10.2147\/OTT.S183192.","journal-title":"Targets Ther"},{"key":"625_CR46","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.ejmech.2017.04.042","volume":"135","author":"R Dutour","year":"2017","unstructured":"Dutour R, Poirier D. Inhibitors of cytochrome P450 (CYP) 1B1, Eur. J Med Chem. 2017;135:296\u2013306. https:\/\/doi.org\/10.1016\/j.ejmech.2017.04.042.","journal-title":"J Med Chem"},{"key":"625_CR47","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1080\/01635581.2012.690928","volume":"64","author":"H Szaefer","year":"2012","unstructured":"Szaefer H, Licznerska B, Krajka-Kuniak V, Bartoszek A, Baer-Dubowska W. Modulation of CYP1A1, CYP1A2 and CYP1B1 expression by cabbage juices and indoles in human breast cell lines. Nutr Cancer. 2012;64:879\u201388. https:\/\/doi.org\/10.1080\/01635581.2012.690928.","journal-title":"Nutr Cancer"},{"key":"625_CR48","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.21873\/anticanres.14356","volume":"40","author":"F Nouriemamzaden","year":"2020","unstructured":"Nouriemamzaden F, Word B, Cotton E, Hawkins A, Littlejohn K, Moore R, Miranda-Carbon G, Orish CN, Lyn-Cook B. Modulation of estrogen \u03b1 and progesterone receptors in triple negative breast cancer cell lines: The effects of vorinostat and indole-3-carbinol in vitro. Anticancer Res. 2020;40:3669\u201383. https:\/\/doi.org\/10.21873\/anticanres.14356.","journal-title":"Anticancer Res"},{"key":"625_CR49","doi-asserted-by":"publisher","unstructured":"Marques M, Laflamme L, Benassou I, Cissokho C, Guillemette B, Gaudreau L. Low levels of 3,3\u2032-diindolylmethane activate estrogen receptor \u03b1 and induce proliferation of breast cancer cells in the absence of estradiol. BMC Cancer. 2014;14. https:\/\/doi.org\/10.1186\/1471-2407-14-524.","DOI":"10.1186\/1471-2407-14-524"},{"key":"625_CR50","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.4161\/15384101.2015.942210","volume":"13","author":"JA Caruso","year":"2014","unstructured":"Caruso JA, Campana R, Wei C, Su CH, Hanks AM, Bornmann WG, Keyomarsi K. Indole-3-carbinol and its N-alkoxy derivatives preferentially target ER\u03b1-positive breast cancer cells. Cell Cycle. 2014;13:2587\u201399. https:\/\/doi.org\/10.4161\/15384101.2015.942210.","journal-title":"Cell Cycle"},{"key":"625_CR51","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/bcpt.13767","volume":"131","author":"G Shilpa","year":"2022","unstructured":"Shilpa G, Lakshmi S, Jamsheena V, Lankalapalli RS, Prakash V, Anbumani S, Priya S. Studies on the mode of action of synthetic diindolylmethane derivatives against triple negative breast cancer cells, Basic Clin. Pharmacol Toxicol. 2022;131:224\u201340. https:\/\/doi.org\/10.1111\/bcpt.13767.","journal-title":"Pharmacol Toxicol"},{"key":"625_CR52","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.cellsig.2017.09.006","volume":"40","author":"H Draz","year":"2017","unstructured":"Draz H, Goldberg AA, Titorenko VI, Tomlinson Guns ES, Safe SH, Sanderson JT. Diindolylmethane and its halogenated derivatives induce protective autophagy in human prostate cancer cells via induction of the oncogenic protein AEG-1 and activation of AMP-activated protein kinase (AMPK). Cell Signal. 2017;40:172\u201382. https:\/\/doi.org\/10.1016\/j.cellsig.2017.09.006.","journal-title":"Cell Signal"},{"key":"625_CR53","doi-asserted-by":"publisher","first-page":"15009","DOI":"10.1039\/C8RA00465J","volume":"8","author":"J Dong","year":"2018","unstructured":"Dong J, Wang Z, Meng Q, Zhang Q, Huang G, Cui J, Li S. Development of 2-arylbenzo[h]quinolone analogs as selective CYP1B1 inhibitors. RSC Adv. 2018;8:15009\u201320. https:\/\/doi.org\/10.1039\/C8RA00465J.","journal-title":"RSC Adv"},{"key":"625_CR54","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1002\/cmdc.201600316","volume":"11","author":"J Dong","year":"2016","unstructured":"Dong J, Zhang Q, Cui Q, Huang G, Pan X, Li S. Flavonoids and naphthoflavonoids: Wider roles in the modulation of cytochrome P450 family 1 enzymes. ChemMedChem. 2016;11:2102\u201318. https:\/\/doi.org\/10.1002\/cmdc.201600316.","journal-title":"ChemMedChem"}],"container-title":["DARU Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-026-00625-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40199-026-00625-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-026-00625-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T03:52:18Z","timestamp":1784692338000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40199-026-00625-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":54,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["625"],"URL":"https:\/\/doi.org\/10.1007\/s40199-026-00625-x","relation":{},"ISSN":["2008-2231"],"issn-type":[{"value":"2008-2231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"2 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"47"}}